FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to antihypotonic agents representing 2-amino-5,6-dihydro-4H-1,3 triazine salts that may be used for creating therapeutic agents for treating hypotension caused by a severe blood loss. What is presented is using seven 2-amino-5,6-dihydro-4H-1,3 triazine salts of general formula I wherein HX=HBr; 2-(AcO)C6H4COOH; 2-(OH)C6H4COOH; CH3(CH2)14COOH; 3,4-(OMe)2 C6H3CH2COOH; C6H5CH2COOH; HOOCCH2CH2COOH, as an antihypotonic agent for treating hypotension caused by a severe blood loss, and a based pharmacological composition for the same applications.
EFFECT: what is shown is the manifested hypotensive property of the known chemical substance in the presence of a severe blood loss.
3 cl, 13 tbl
Title | Year | Author | Number |
---|---|---|---|
ANTIANTIHYPERTENSIVE | 2007 |
|
RU2338538C1 |
ANTIHYPOTENSION MEDICATION | 2007 |
|
RU2353614C1 |
VASOPRESSOR AGENT | 2013 |
|
RU2552529C1 |
VASOCONSTRICTOR | 2011 |
|
RU2475479C1 |
4-ARYL (HETARIL) METHYL-SUBSTITUTED 8-CYCLOPENTILAMINE-5,7-DIFLUOR-3,4-DIHYDRO-2H-BENZO [1,4] THIAZINE-1,1-DIOXIDES THAT HYPERTENSIVE ACTION | 2016 |
|
RU2627499C1 |
METHOD FOR PREMEDICATION IN PATIENTS WITH A LOCAL KIDNEY CANCER WITH ARTERIAL HYPERTENSION CONTROLLED BY ANGIOTENSINE TRANSFORMING ENZYME INHIBITORS | 2018 |
|
RU2681496C1 |
MEDICINAL AGENT | 2007 |
|
RU2363463C1 |
AGENT EFFECTING ON ARTERIAL PRESSURE | 1997 |
|
RU2187309C2 |
FLUORATED 4-FURFURYL-3,4-DIHYDRO-2H-BENZO[1,4]THIAZINE-1,1-DIOXIDES WITH HIGH ARRYTHMIC ACTIVITY | 2016 |
|
RU2626239C1 |
AGENT POSSESSING ANTIARRHYTHMIC, ANTIFIBRILLATORY, ANTI-ISCHEMIC ACTION, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2477130C1 |
Authors
Dates
2014-02-10—Published
2011-05-24—Filed